Puteaux, Ile-de-France, France The venture was found in Europe in France. The main department of described Corporate Investor is located in the Puteaux.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Health Care. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Cardiawave.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Angels Santu00e9, startups are often financed by AGORANOV, Wilco, Paris Business Angels. The meaningful sponsors for the fund in investment in the same round are Paris Business Angels, Business Angels des Grandes Ecoles, Femmes Business Angels. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, Sofimac Innovation, Ru00e9gion Sud Investissement.
The common things for fund are deals in the range of 1 - 5 millions dollars. Considering the real fund results, this Corporate Investor is 9 percentage points less often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2017.
Related Funds
| Fund Name | Location |
| Advertising, Art & Ideas | Switzerland, Zürich, Zurich |
| Avery Dennison | California, Glendale, United States |
| Base Case Capital | California, San Francisco, United States |
| Changcheng Zhangfu Touzi | China, Guangdong, Shenzhen |
| FamilySearch | Salt Lake City, United States, Utah |
| Jiuhe Venture Capital | - |
| KP Engineering | Texas, Tyler, United States |
| LMCG Investments | Boston, Massachusetts, United States |
| RCM Business | Bhilwara, India, Rajasthan |
| Riceland HealthCare | Texas, United States, Winnie |
| Sarissa Capital Management | - |
| Selva Ventures | California, San Francisco, United States |
| Singh Capital Partners | Maryland, Potomac, United States |
| SKU | Austin, Texas, United States |
| TechnoStart | Germany, Ludwigsburg, Mecklenburg-Vorpommern |
| TF1 Group | Boulogne, France, Nord-Pas-de-Calais |
| UHT Investments | Dubai, United Arab Emirates |
| Zinnov | California, Santa Clara, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
SeaBeLife | $1M | 26 Sep 2023 | Bretagne, Brittany, France | ||
Abcely | $2M | 21 Sep 2023 | Nantes, Pays de la Loire, France | ||
Odimma | $2M | 13 Apr 2023 | Illkirch-graffenstaden, Alsace, France | ||
Ensweet | $2M | 23 Feb 2023 | Nord-Pas-de-Calais, Hauts-de-France, France | ||
Healshape | $7M | 28 Jun 2022 | Villeurbanne, Rhone-Alpes, France | ||
Vaxxel | $1M | 18 Mar 2022 | Villeurbanne, Rhone-Alpes, France | ||
Mapatho | $1M | 03 May 2021 | Paris, Ile-de-France, France | ||
Gaoma Therapeutics | $1M | 14 Apr 2021 | France, Auvergne-Rhône-Alpes, France | ||
OncoDiag | $2M | 15 Mar 2021 | France, Auvergne-Rhône-Alpes, France |
– OncoDiag, a Miserey, near Evreux, France-based company specializing in the development of diagnostic tests for the early detection of cancer, raised €2.5m ($3M) in Series A funding.
– The funding was led by Angels Santé, Business Angels des Grandes Ecoles (BADGE), Normandie Business Angels (NBA), Paris Business Angels (PBA), and the Société de Financement de l’Innovation Numérique en Essonne (SFINE).
– The Region of Normandy also contributed to this round of financing and will be joining the pool of investors, via Normandie Participations.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
SeaBeLife | $1M | 26 Sep 2023 | Bretagne, Brittany, France | ||
Abcely | $2M | 21 Sep 2023 | Nantes, Pays de la Loire, France | ||
Odimma | $2M | 13 Apr 2023 | Illkirch-graffenstaden, Alsace, France | ||
Ensweet | $2M | 23 Feb 2023 | Nord-Pas-de-Calais, Hauts-de-France, France | ||
Healshape | $7M | 28 Jun 2022 | Villeurbanne, Rhone-Alpes, France | ||
Vaxxel | $1M | 18 Mar 2022 | Villeurbanne, Rhone-Alpes, France | ||
Mapatho | $1M | 03 May 2021 | Paris, Ile-de-France, France | ||
Gaoma Therapeutics | $1M | 14 Apr 2021 | France, Auvergne-Rhône-Alpes, France | ||
OncoDiag | $2M | 15 Mar 2021 | France, Auvergne-Rhône-Alpes, France |
